Ipca Laboratories Ltd. - Research Center
524494 IPCALAB Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 25.37 | 25.37 | 25.27 | 25.27 | 25.24 |
| Share application money | - | - | 11.94 | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 5,497.97 | 4,727.35 | 3,640.33 | 3,111.39 | 2,669.71 |
| Loan funds | |||||
| Secured loans | 761.01 | 223.20 | 387.65 | 329.80 | 473.05 |
| Unsecured loans | - | - | - | - | - |
| Total | 6,284.35 | 4,975.92 | 4,065.19 | 3,466.46 | 3,168.00 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 3,210.57 | 2,822.88 | 2,632.80 | 2,373.28 | 2,327.10 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 1,125.79 | 954.28 | 791.83 | 633.18 | 472.49 |
| Net block | 2,084.78 | 1,868.60 | 1,840.97 | 1,740.10 | 1,854.61 |
| Capital work-in-progress | 289.04 | 182.00 | 84.19 | 65.96 | 73.23 |
| Investments | 1,447.52 | 867.84 | 648.72 | 322.24 | 215.63 |
| Net current assets | |||||
| Current assets, loans & advances | 3,645.52 | 3,091.69 | 2,610.69 | 2,329.24 | 1,964.24 |
| Less : current liabilities & provisions | 1,182.51 | 1,034.21 | 1,119.38 | 991.08 | 939.71 |
| Total net current assets | 2,463.01 | 2,057.48 | 1,491.31 | 1,338.16 | 1,024.53 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 6,284.35 | 4,975.92 | 4,065.19 | 3,466.46 | 3,168.00 |
| Notes: | |||||
| Book value of unquoted investments | 25.19 | - | - | - | - |
| Market value of quoted investments | 719.31 | 393.83 | 238.25 | 90.38 | 69.35 |
| Contingent liabilities | 287.71 | 382.20 | 219.49 | 164.84 | 80.65 |
| Number of equity sharesoutstanding (Lacs) | 2537.04 | 1268.52 | 1263.52 | 1263.52 | 1261.99 |
Mutual Fund Selector
Find the fund that is right for you
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis